Eton Pharmaceuticals Inc
ETON - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.84B
Close$
$2.87
95.5% downside
Current Fair Value
95.5% downsideOvervalued by 95.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.84 Billion |
|---|---|
| Enterprise Value | $1.81 Billion |
| Earnings per Share | $-0.17 |
| Beta | 0.83 |
| Outstanding Shares | 28,660,515 |
Return
| Return on Equity | 57.37% |
|---|---|
| Return on Assets | 31.71% |
| Return on Invested Capital | 39.73% |
Valuation & Multiples
| P/E Ratio | 36.22 |
|---|---|
| PEG | -1.88 |
| Price to Sales | 15.98 |
| Price to Book Ratio | 21.31 |
| Enterprise Value to Revenue | 12.85 |
| Enterprise Value to EBIT | 44.22 |
| Enterprise Value to Net Income | 36 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 5, 2026
EPS
$0.50
Est. $0.31Revenue
$57.92 M
Est. $41.98 MNext Earnings Call
Expected Date
March 18, 2027
EPS Estimate
$0.39
Consensus analyst estimateRevenue Estimate
$60.16 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 83.15% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 9.55%▼ 62.96% |
|---|---|
| Total Invested | $136.03M▼ 81.25% |
| Investors Holding | 84▼ 88.00% |
About Eton Pharmaceuticals Inc
16 employees
Eton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company currently owns or receives royalties from three FDA-approved products, including ALKIN...